Iron-activated molecules show promise against aggressive, treatment-resistant cancer cells

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively eliminate specific cancer cells able to adapt to existing treatments and which exhibit high metastatic potential. Yet metastases are responsible for 70% of cancer deaths.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup